L‑Carnitine
A supplement and a medicine, also used as a fat burner; it carries fatty acids into the cell's energy-producing part.

DETAILED OVERVIEW
What is L-Carnitine?
L-carnitine (L-Carnitine) is a substance the body also makes itself, from lysine and methionine, two amino acids. As a medicine it is approved to treat primary carnitine deficiency; as a supplement it is available without a prescription as capsules or a solution, while the injectable form needs a prescription. Athletes and people trying to lose weight use it as a fat burner.
In cells it acts as a carrier: it brings fatty acids into the mitochondria (the cell's energy-producing part), where they are burned. In studies, after prolonged use together with carbohydrate, the carnitine level in muscle rose two- to three-fold. Taken by mouth in larger amounts, it often causes diarrhea, nausea and a fishy body odor. Together with blood thinners such as warfarin it can raise the risk of bleeding. Only the L-form is useful; the D-form may be toxic to the heart, so a mixed (D,L) product can be dangerous. It is not on the WADA prohibited list, but the German anti-doping agency monitors very large amounts given intravenously.
Mechanism of action
Long-chain fatty acid CoA-mediated mitochondrial shuttle (CPT-I/II), rate-limiting step of β-oxidation
Half-life
~15 hours (parent compound), muscle loading steady-state 3-4 weeks chronic
Onset
Oral 1-2 hours (low bioavailability ~15%); IM/SC 30-60 minutes (100% bioavailability)
Legal status
Medicine (for carnitine deficiency) and dietary supplement; not banned
Community reports describe injectable L-carnitine as a long-term daily staple rather than a quick fix: users note better day-to-day energy even on its own, and typically administer it pre-workout together with carbohydrates to maximise muscle uptake. It is consistently framed as "not a magic fat burner" – the visible effect appears when combined with a proper routine and a caloric deficit, and reports frequently stack it with Cardarine during cutting phases.
Two practical notes recur across reports: it is a water-based compound that must never be mixed with oil-based preparations, and consistent daily dosing is considered key to keeping tissue saturation stable.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Stephens FB, Constantin-Teodosiu D, Greenhaff PL. . New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol. 2007;581(Pt 2):431-444..
Wall BT, Stephens FB, Constantin-Teodosiu D et al. . Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol. 2011;589(Pt 4):963-973..
Koeth RA, Wang Z, Levison BS et al. . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585..
Kraemer WJ, Volek JS, French DN et al. . L-carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. J Strength Cond Res. 2003;17(3):455-462..
Talenezhad N, Mohammadi M, Ramezani-Jolfaie N et al. . Effects of L-carnitine on weight loss and body composition: a meta-analysis of 37 randomized controlled clinical trials. Clin Nutr ESPEN. 2020;37:9-23..
Safety
Side effects, stop signs, contraindications
Side effects · 8
- Gastrointestinal upset: diarrhea, nausea, abdominal cramps, heartburn, especially at oral doses >2 g/day (the most common, dose-dependent side effect).
- Fishy body odor (trimethylaminuria-like): gut bacteria produce trimethylamine from carnitine, causing a fishy smell in sweat, breath and urine, typically at >2 g/day.
- Elevated serum TMAO (trimethylamine-N-oxide) with chronic high-dose use (>2 g/day, 6+ months); an atherosclerosis risk-marker, though its causal role is debated (Koeth 2013 vs Yancey 2018).
- Injectable form (IM/SC): painful injection (PIP), local irritation from the quaternary-ammonium vehicle, rarely sterile abscess or transient local redness and warmth.
- Rare allergic/histamine-release reaction with parenteral dosing (flushing, itching, hypotension); a 0.5 g test dose is advised for the first IM/SC injection.
- Thyroid interaction: carnitine inhibits peripheral T4-to-T3 conversion, which in patients treated for hypothyroidism may worsen symptoms or require levothyroxine dose adjustment (Benvenga 2001).
- Warfarin/anticoagulant interaction: chronic carnitine dosing can raise INR, increasing bleeding risk; INR monitoring is required (Martinez 2007).
- Rarely restlessness, mild stimulant-like feeling and sleep disturbance at higher doses; through lowering of the seizure threshold, increased seizure frequency has been reported in predisposed individuals.
Contraindications · 7
- Seizure disorder (epilepsy) or a condition predisposing to seizures: carnitine may rarely lower the seizure threshold and increase seizure frequency, so caution is required.
- Severe renal failure / dialysis (ESRD): dose adjustment is needed due to reduced renal clearance, and D,L-carnitine (racemic OTC) must be strictly avoided because of the D-isomer's cardiotoxic/myasthenic risk.
- Concurrent warfarin or other coumarin anticoagulant: due to the risk of elevated INR and bleeding, only with close INR monitoring under medical supervision.
- Treated hypothyroidism (on levothyroxine): carnitine weakens the peripheral action of thyroid hormone, which can reduce treatment efficacy; dose monitoring is required.
- Known hypersensitivity to L-carnitine (or any component of the formulation); for the parenteral form, a prior histamine/allergic reaction to injection.
- Pregnancy and breastfeeding without an Rx indication: supplement-dose is FDA category B, but high-dose IM/SC parenteral use is not recommended without medical indication.
- Overlap with carnitine supplementation during valproate therapy: valproate can cause carnitine deficiency and is often therapeutically supplemented, so cycle-level supplementation only in consultation with the treating physician.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle
Stephens FB, Constantin-Teodosiu D, Greenhaff PL.
Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans
Wall BT, Stephens FB, Constantin-Teodosiu D et al.
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth RA, Wang Z, Levison BS et al.
L-carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress
Kraemer WJ, Volek JS, French DN et al.
Effects of L-carnitine on weight loss and body composition: a meta-analysis of 37 randomized controlled clinical trials
Talenezhad N, Mohammadi M, Ramezani-Jolfaie N et al.
Telegram
Have a question about L‑Carnitine?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.